Minhwan Kim, MD | |
8901 Wisconsin Ave, Bethesda, MD 20889-0004 | |
(301) 295-0537 | |
Not Available |
Full Name | Minhwan Kim |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 8901 Wisconsin Ave, Bethesda, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740922459 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 0101279638 (Virginia) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | 0101279638 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Minhwan Kim, MD 8901 Wisconsin Ave, Bethesda, MD 20889-0004 Ph: (301) 295-0537 | Minhwan Kim, MD 8901 Wisconsin Ave, Bethesda, MD 20889-0004 Ph: (301) 295-0537 |
News Archive
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.
Long-term light smokers appear to be at greater risk for lung function decline, emphysema and obstructive lung disease than heavy smokers who quit, according to new research presented at the ATS 2018 International Conference.
Jiangbo Pharmaceuticals, Inc., today announced that the Company received approval from the Shandong Food and Drug Administration to start the sales of Felodipine sustained release tablets.
Scientists at the University of Warwick have provided the first evidence that the lack of a naturally occurring protein is linked to early signs of dementia.
› Verified 1 days ago